Nitta Gelatin India Ltd

Nitta Gelatin Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nitta Gelatin India Ltd

₹ 934 -0.09%
24 Apr - close price
gelatin.in BSE: 506532
About

Nitta Gelatin India Ltd is primarily engaged in the manufacture and sale of ossein, gelatin and collagen peptide.[1]

Key Points

Product Portfolio
The company's product portfolio includes wellnex collagen peptides, gelatin, Di calcium phosphate, chitosan, and a few consumer products. [1] The products are used for pharmaceutical, agricultural, industrial, and food applications. [2]

Website BSE
  • Market Cap ₹ 848 Cr.
  • Current Price ₹ 934
  • High / Low ₹ 1,184 / 697
  • Stock P/E 10.6
  • Book Value ₹ 311
  • Dividend Yield 0.80 %
  • ROCE 30.6 %
  • ROE 27.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 73.1% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
92 94 91 103 116 118 113 125 119 130 116 123 118
79 88 84 94 99 102 98 104 89 107 82 97 91
Operating Profit 13 6 8 10 17 16 15 21 31 23 34 27 27
OPM % 14% 7% 8% 9% 14% 14% 14% 17% 26% 17% 29% 22% 23%
0 1 1 3 1 0 1 5 0 0 2 9 0
Interest 1 1 1 1 1 1 1 2 1 0 0 0 0
Depreciation 4 4 3 3 3 3 3 3 3 3 3 4 4
Profit before tax 8 3 4 8 13 12 12 20 27 19 33 32 23
Tax % 29% 39% 25% 30% 29% 30% 29% 23% 22% 28% 25% 21% 29%
6 2 3 5 10 9 8 16 21 14 24 25 17
EPS in Rs 6.26 1.70 3.39 5.87 10.46 9.57 9.31 17.34 22.85 15.23 26.97 27.63 18.29
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
244 303 287 355 357 341 343 261 294 354 429 487 487
223 263 277 329 318 304 316 243 268 314 378 397 377
Operating Profit 21 40 10 27 39 37 27 18 27 40 51 90 110
OPM % 8% 13% 3% 8% 11% 11% 8% 7% 9% 11% 12% 18% 23%
1 2 0 2 2 9 5 1 3 5 6 5 12
Interest 6 7 6 8 6 4 7 8 8 5 5 4 1
Depreciation 9 10 11 10 9 10 14 14 15 15 14 13 14
Profit before tax 7 26 -7 10 26 32 11 -4 7 24 38 78 107
Tax % 22% 40% 32% 49% 37% 36% 65% 28% -15% 26% 29% 25%
5 16 -5 5 17 20 4 -3 8 18 27 59 80
EPS in Rs 4.54 13.91 -5.46 5.62 18.38 22.57 4.16 -2.91 8.70 19.72 29.30 64.72 88.12
Dividend Payout % 66% 22% 0% 18% 14% 11% 60% -52% 29% 15% 14% 12%
Compounded Sales Growth
10 Years: 5%
5 Years: 7%
3 Years: 18%
TTM: 2%
Compounded Profit Growth
10 Years: 14%
5 Years: 73%
3 Years: 95%
TTM: 49%
Stock Price CAGR
10 Years: 25%
5 Years: 50%
3 Years: 80%
1 Year: 4%
Return on Equity
10 Years: 10%
5 Years: 13%
3 Years: 19%
Last Year: 28%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 8 8 9 9 9 9 9 9 9 9 9 9 9
Reserves 99 111 106 113 125 130 138 133 134 154 176 231 274
Preference Capital 0 0 0 0 16 0 0 0 0 0 4 4
36 42 53 53 54 84 104 101 79 75 76 29 16
36 41 42 40 61 48 55 51 53 49 55 57 54
Total Liabilities 180 202 210 214 249 271 305 295 276 287 316 326 354
69 68 82 77 80 77 110 126 116 108 102 109 108
CWIP 6 8 8 8 7 11 10 3 4 2 7 7 8
Investments 8 32 32 32 45 27 4 4 4 4 4 5 5
96 93 88 96 117 157 181 161 151 172 202 206 233
Total Assets 180 202 210 214 249 271 305 295 276 287 316 326 354

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
20 16 23 17 29 11 26 28 33 15 13 78
-18 -11 -24 -8 -22 -3 -7 -13 -7 -3 -11 -15
-1 -4 0 -8 11 -6 -20 -14 -29 -12 -2 -53
Net Cash Flow 0 -0 -0 1 18 2 -0 1 -3 -0 -1 10

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 26 31 28 23 21 56 65 74 34 57 65 59
Inventory Days 119 138 129 99 112 127 151 202 220 161 148 133
Days Payable 60 55 80 50 43 37 56 67 58 46 30 45
Cash Conversion Cycle 86 114 77 72 90 147 160 210 196 172 182 148
Working Capital Days 62 69 61 61 59 101 92 103 72 103 114 92
ROCE % 9% 22% -1% 11% 17% 17% 7% 2% 6% 13% 17% 31%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
74.48% 74.48% 74.48% 74.48% 74.48% 74.49% 74.49% 74.49% 74.49% 74.49% 74.49% 74.49%
0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.26% 0.26% 0.12% 0.12% 0.12%
25.40% 25.40% 25.40% 25.40% 25.40% 25.41% 25.41% 25.26% 25.26% 25.41% 25.40% 25.40%
No. of Shareholders 6,0146,5726,3576,3756,3997,5938,6508,3328,46610,18311,02811,573

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings